Lastest News


440 companies founded last year, giving prediction of 2nd bio-venture boom

The 2nd bio-venture boom was predicted as more than 440 bio small and medium companies were founded last year.  According to data of the ‘Korean biotechnology small and medium venture foundation status’ recently publ...

What are 8 pharmaceutical policies suggested to Planning Advisory Committee for National Affairs?

While the Jae-In Moon administration shared empathy about ‘medical publicity’ with 5 medical associations, the Korean Pharmaceutical Association(hereinafter referring to KPA) suggested 8 pending policy issues includin...

“Saudi Arabia is considering a 30-approval process for Korean drugs”

“We are considering a 30-day approval process for pharmaceutical products that are already approved from the Korean Ministry of Food and Drug Safety.” Mr. Al-Hariri, a person in charge for pharmaceutical affairs in S...

MFDS revises indicated information on OTC drugs to be easily understood

On the 20th of June, the Ministry of Food and Drug Safety pre-announced a partial revision bill to the ‘Regulations for Pharmaceutical Drug Labeling’ having creation of the entire substance indication method with indi...

Hanmi’s 3-sbustance combination drug containing Amosartan & rosuvastatin represented at EHS

2 case results of clinical trial for ‘Amosartan,’ a combination drug developed by Hanmi Pharm, were announced at the European Society of Hypertension(ESH). Hanmi Pharm announced on the 20th that it presented a Phase ...

Government conducts study about detailed plans for ‘introduction of public pharmaceutical control tower’

The government will start a study of detailed plan for the ‘Introduction of Pharmaceutical Control Tower’ to supply essential drugs. In the process, it will review various aspects, such as definition of essential drug...

MFDS strengthens post-marketing drug safety management

The Ministry of Food and Drug Safety(MFDS) will strengthen post-marketing drug safety control to minimize consumer damages from drug side effects. In order to overcome unexpected side effects after pharmaceutical app...

‘Aggregation Labeling Standards’ approaching

The ‘Aggregation Labeling Standards,’ a key factor of implementing the serial number reporting system next month, is going to be completed soon. The government – Ministry of Health and Welfare(MOHW) & Health Insuranc...

MFDS provides information about approval expiration date in preparation of product renewal system

In order to give a guidance about details of the ‘Pharmaceutical Product Renewal System’ which will be enforced from coming July, the Ministry of Food and Drug Safety(MFDS) will open the ‘Information Room about Pharma...

SK Biotek acquires Bristol-Myers Squibb’s factory in Ireland

SK Group will acquire a factory of Bristol-Myers Squibb(BMS), a global pharmaceutical company, in Ireland. “Our subsidiary, SK Biotek, will acquire a Bristol-Myers Squibb’s large pharmaceutical ingredient factory(pro...

How will they handle return of pharmaceutical products without serial number?

About 10 days ahead of the drug serial number reporting system, the pharmaceutical distribution industry is immediately having serious troubles from recruiting additional human resources, expanding facilities and retu...

Pentavalent combination vaccine ‘DTaP-IPV/Hib’ introduced in Korea

A pentavalent vaccine(DTaP-IVP/Hib), which prevent diphtheria, tetanus, whooping cough, polio and haemophilus influenzae type b, will be introduced. The Korea Centers for Disease Control and Prevention(Director Ki-Su...

Will AI be used in new drug development in Korea?

Will new drug development using artificial intelligence(AI) take a first step in Korea? On the 14th, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won, KPBMA) had a demand survey,...

MSDF working on allowing GMP factories to manufacture animal drugs

Pharmaceutical companies manufacturing pharmaceutical products for human use are expected to be available to manufacture pharmaceutical products for both human and animal use. In order to improve quality of veterinar...

Huons Global will participate in ‘U.S. Bio International Convention’

Huons Global(CEO Sung-Tae Yoon, Wan-Sup Kim) announced plans to participate in the ‘Bio International Convention,’ the world’s largest bio event, from the 19th in San Diego and intensively focus on promoting ‘Hutox,’ ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.